DexCom, Inc. (LON:0A4M)

Market Cap	19.74B
Revenue (ttm)	3.22B
Net Income (ttm)	460.25M
Shares Out	n/a
EPS (ttm)	1.14
PE Ratio	42.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76
Average Volume	2,671
Open	66.59
Previous Close	n/a
Day's Range	66.59 - 66.59
52-Week Range	49.56 - 112.76
Beta	n/a
RSI	32.61
Earnings Date	Apr 24, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A4M

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD